Redcare Pharmacy (0RJT) Share Forecast & Price Target

Compare

8 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0RJT Analyst Ratings

Moderate Buy

7 Buy

2 Hold

1 Sell

Based on 10 analysts giving stock ratings to

Redcare

Pharmacy

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0RJT Stock 12 Month Forecast

Average Price Target

€167.60

▲(68.49%Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Redcare Pharmacy in the last 3 months. The average price target is €167.60 with a high forecast of €214.00 and a low forecast of €94.00. The average price target represents a 68.49% change from the last price of €99.47.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"93":"€93","154":"€154","215":"€215","123.5":"€123.5","184.5":"€184.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":214,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€214.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":167.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€167.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":94,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€94.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[93,123.5,154,184.5,215],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,113.39,121.12923076923077,128.86846153846153,136.6076923076923,144.34692307692308,152.08615384615385,159.82538461538462,167.56461538461537,175.30384615384617,183.0430769230769,190.7823076923077,198.52153846153846,206.26076923076923,{"y":214,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,113.39,117.56,121.73,125.9,130.07,134.24,138.41,142.57999999999998,146.75,150.92000000000002,155.09,159.26,163.43,{"y":167.6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,113.39,111.89846153846153,110.40692307692308,108.91538461538461,107.42384615384616,105.93230769230769,104.44076923076923,102.94923076923077,101.45769230769231,99.96615384615384,98.47461538461539,96.98307692307692,95.49153846153845,{"y":94,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":114.07,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.3,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 8</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":138.1,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 8</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.3,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":135.62,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":142.11,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":149.8,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":132.8,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":120.45,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":116.36,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":120.35,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":129.69,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":113.39,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€214.00

Average Price Target€167.60

Lowest Price Target€94.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jan KochDeutsche Bank

Deutsche Bank

€214

Buy

115.14%

Upside

Reiterated

06/05/25

Deutsche Bank Sticks to Their Buy Rating for Redcare Pharmacy (0RJT)

Sven SauerKepler Capital

Kepler Capital

€150→€130

Hold

30.69%

Upside

Downgraded

06/04/25

Redcare Pharmacy (0RJT) was downgraded to a Hold Rating at Kepler Capital

Martin ComtesseJefferies

Jefferies

€170

Buy

70.91%

Upside

Reiterated

06/04/25

Jefferies Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)

Gerhard OrgonasBerenberg Bank

Berenberg Bank

€200

Buy

101.07%

Upside

Reiterated

05/07/25

Berenberg Bank Sticks to Their Buy Rating for Redcare Pharmacy (0RJT)

Christian SalisHauck & Aufhaeuser

Hauck & Aufhaeuser

€175→€170

Buy

70.91%

Upside

Reiterated

05/07/25

Hauck & Aufhaeuser Sticks to Their Buy Rating for Redcare Pharmacy (0RJT)

Olivier CalvetUBS

UBS

€94

Sell

-5.50%

Downside

Reiterated

05/06/25

UBS Keeps Their Sell Rating on Redcare Pharmacy (0RJT)

Michael HeiderWarburg Research

Warburg Research

€195→€186

Buy

86.99%

Upside

Reiterated

05/06/25

Warburg Research Keeps Their Buy Rating on Redcare Pharmacy (0RJT)

Volker BosseBaader Bank

Baader Bank

€175

Buy

75.93%

Upside

Reiterated

05/06/25

Baader Bank Sticks to Its Buy Rating for Redcare Pharmacy (0RJT)

Yannik SieringStifel Nicolaus

Stifel Nicolaus

€190

Buy

91.01%

Upside

Reiterated

04/04/25

Strong Customer Growth and Margin Improvement Justify Buy Rating for Redcare Pharmacy

Aisyah NoorMorgan Stanley

Morgan Stanley

€140→€147

Hold

47.78%

Upside

Reiterated

03/12/25

Redcare Pharmacy NV (RDC:GR) PT Raised to EUR147 at Morgan StanleyMorgan Stanley analyst Aisyah Noor raised the price target on Redcare Pharmacy NV (RDC:GR) to EUR147.00 (from EUR140.00) while maintaining a Equalweight rating.

Christopher JohnenHSBC

HSBC

€140→€155

Buy

55.83%

Upside

Upgraded

10/02/24

HSBC Upgrades Redcare Pharmacy NV (RDC:GR) to BuyHSBC analyst Christopher Johnen upgraded Redcare Pharmacy NV (RDC:GR) from Hold to Buy with a price target of EUR155.00 (from EUR140.00).

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jan KochDeutsche Bank

Deutsche Bank

€214

Buy

115.14%

Upside

Reiterated

06/05/25

Deutsche Bank Sticks to Their Buy Rating for Redcare Pharmacy (0RJT)

Sven SauerKepler Capital

Kepler Capital

€150→€130

Hold

30.69%

Upside

Downgraded

06/04/25

Redcare Pharmacy (0RJT) was downgraded to a Hold Rating at Kepler Capital

Martin ComtesseJefferies

Jefferies

€170

Buy

70.91%

Upside

Reiterated

06/04/25

Jefferies Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)

Gerhard OrgonasBerenberg Bank

Berenberg Bank

€200

Buy

101.07%

Upside

Reiterated

05/07/25

Berenberg Bank Sticks to Their Buy Rating for Redcare Pharmacy (0RJT)

Christian SalisHauck & Aufhaeuser

Hauck & Aufhaeuser

€175→€170

Buy

70.91%

Upside

Reiterated

05/07/25

Hauck & Aufhaeuser Sticks to Their Buy Rating for Redcare Pharmacy (0RJT)

Olivier CalvetUBS

UBS

€94

Sell

-5.50%

Downside

Reiterated

05/06/25

UBS Keeps Their Sell Rating on Redcare Pharmacy (0RJT)

Michael HeiderWarburg Research

Warburg Research

€195→€186

Buy

86.99%

Upside

Reiterated

05/06/25

Warburg Research Keeps Their Buy Rating on Redcare Pharmacy (0RJT)

Volker BosseBaader Bank

Baader Bank

€175

Buy

75.93%

Upside

Reiterated

05/06/25

Baader Bank Sticks to Its Buy Rating for Redcare Pharmacy (0RJT)

Yannik SieringStifel Nicolaus

Stifel Nicolaus

€190

Buy

91.01%

Upside

Reiterated

04/04/25

Strong Customer Growth and Margin Improvement Justify Buy Rating for Redcare Pharmacy

Aisyah NoorMorgan Stanley

Morgan Stanley

€140→€147

Hold

47.78%

Upside

Reiterated

03/12/25

Christopher JohnenHSBC

HSBC

€140→€155

Buy

55.83%

Upside

Upgraded

10/02/24

HSBC Upgrades Redcare Pharmacy NV (RDC:GR) to BuyHSBC analyst Christopher Johnen upgraded Redcare Pharmacy NV (RDC:GR) from Hold to Buy with a price target of EUR155.00 (from EUR140.00).

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Redcare Pharmacy

1 Month

xxx

Success Rate

24/33 ratings generated profit

Average Return

+4.08%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 72.73% of your transactions generating a profit, with an average return of +4.08% per trade.

3 Months

xxx

Success Rate

23/32 ratings generated profit

Average Return

+21.21%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 71.88% of your transactions generating a profit, with an average return of +21.21% per trade.

1 Year

Olivier CalvetUBS

Success Rate

31/38 ratings generated profit

Average Return

+39.10%

reiterated a sell rating last month

Copying Olivier Calvet's trades and holding each position for 1 Year would result in 76.32% of your transactions generating a profit, with an average return of +39.10% per trade.

2 Years

xxx

Success Rate

30/38 ratings generated profit

Average Return

+60.79%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 78.95% of your transactions generating a profit, with an average return of +60.79% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0RJT Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0RJT has received 17 Buy Ratings, 1 Hold Ratings, and 2 Sell Ratings. 0RJT average Analyst price target in the past 3 months is 167.60.

Each month's total comprises the sum of three months' worth of ratings.

0RJT Financial Forecast

0RJT Earnings Forecast

Next quarter’s earnings estimate for 0RJT is -€0.21 with a range of -€0.21 to -€0.21. The previous quarter’s EPS was -€0.50. 0RJT beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year 0RJT has Outperformed its overall industry.

0RJT Sales Forecast

Next quarter’s sales forecast for 0RJT is €710.85M with a range of €709.70M to €712.00M. The previous quarter’s sales results were €717.29M. 0RJT beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.56% of the time in the same period. In the last calendar year 0RJT has Outperformed its overall industry.

0RJT Stock Forecast FAQ

What is GB:0RJT’s average 12-month price target, according to analysts?

Based on analyst ratings, Redcare Pharmacy’s 12-month average price target is 167.60.

What is GB:0RJT’s upside potential, based on the analysts’ average price target?

Redcare Pharmacy has 68.49% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Redcare Pharmacy a Buy, Sell or Hold?

Redcare Pharmacy has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 2 hold ratings and 1 sell ratings.

What is Redcare Pharmacy’s share price target?

The average share price target for Redcare Pharmacy is 167.60. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €214.00 ,and the lowest forecast is €94.00. The average share price target represents 68.49% Increase from the current price of €99.47.

What do analysts say about Redcare Pharmacy?

Redcare Pharmacy’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of Redcare Pharmacy?

To buy shares of GB:0RJT, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Redcare Pharmacy (0RJT) Share Forecast & Price Target

0RJT Analyst Ratings

0RJT Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Redcare Pharmacy

0RJT Analyst Recommendation Trends

0RJT Financial Forecast

0RJT Earnings Forecast

0RJT Sales Forecast

0RJT Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts